RU2018104707A - ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА - Google Patents

ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА Download PDF

Info

Publication number
RU2018104707A
RU2018104707A RU2018104707A RU2018104707A RU2018104707A RU 2018104707 A RU2018104707 A RU 2018104707A RU 2018104707 A RU2018104707 A RU 2018104707A RU 2018104707 A RU2018104707 A RU 2018104707A RU 2018104707 A RU2018104707 A RU 2018104707A
Authority
RU
Russia
Prior art keywords
human
respiratory
il12ρ40
molecular markers
infections caused
Prior art date
Application number
RU2018104707A
Other languages
English (en)
Other versions
RU2707549C2 (ru
RU2018104707A3 (ru
Inventor
Сусан Марсела БУЕНО РАМИРЕЗ
Хосе Пабло БЕРТРАНД НАВАРРЕТЕ
Маргарита Кам-Лем ЛАЙ РЕМОЛКОИ
ПАРРА Алексис Микес КАЛЛЕРГИС
Original Assignee
Понтифисиа Универсидад Католика Дэ Чиле
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Понтифисиа Универсидад Католика Дэ Чиле filed Critical Понтифисиа Универсидад Католика Дэ Чиле
Publication of RU2018104707A publication Critical patent/RU2018104707A/ru
Publication of RU2018104707A3 publication Critical patent/RU2018104707A3/ru
Application granted granted Critical
Publication of RU2707549C2 publication Critical patent/RU2707549C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5403—IL-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5434—IL-12
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/54—Determining the risk of relapse

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Claims (6)

1. Применение молекулярных маркеров IL-3, IL-12p40 и IL-33, отличающееся тем, что они служат для прогнозирования рецидивирующей бронхиальной обструкции и астмы после бронхиолита, вызванных респираторно-синцитиальным вирусом человека (SRV).
2. Применение по п. 1, отличающееся тем, что одна из респираторных инфекций представлена бронхиолитом.
3. Способ прогнозирования рецидивирующей бронхиальной обструкции и астмы после бронхиолита, вызванных респираторно-синцитиальным вирусом человека (SRV), отличающийся тем, что он включает:
амплификацию и обнаружение с помощью молекулярно-биологической процедуры, например, PCR и ELISA, с использованием маркеров IL-3, IL-12p40 и IL-33;
подсчет сверхэкспрессии последовательности-мишени в дополнение к маркерам IL-3, IL-33 или IL-12p40;
соотношение на основании количественного определения полученной сверхэкспрессии и развития болезни, вызванной SRV: высокая вероятность развития бронхиальной обструкции, если концентрация в бронхоальвеолярных выделениях превышает 500 пг/мл IL-12p40 или IL-3; высокая вероятность развитие астмы, если концентрация в бронхоальвеолярных выделениях превышает 500 пг/мл IL-33.
RU2018104707A 2015-07-31 2016-07-25 ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА RU2707549C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CL2015002153A CL2015002153A1 (es) 2015-07-31 2015-07-31 Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano
CL201502153 2015-07-31
PCT/IB2016/054423 WO2017021814A1 (en) 2015-07-31 2016-07-25 Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus

Publications (3)

Publication Number Publication Date
RU2018104707A true RU2018104707A (ru) 2019-08-28
RU2018104707A3 RU2018104707A3 (ru) 2019-08-28
RU2707549C2 RU2707549C2 (ru) 2019-11-27

Family

ID=56081023

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018104707A RU2707549C2 (ru) 2015-07-31 2016-07-25 ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА

Country Status (17)

Country Link
US (1) US11085080B2 (ru)
EP (1) EP3329019B1 (ru)
KR (1) KR102621463B1 (ru)
CN (1) CN108368556B (ru)
AR (1) AR105542A1 (ru)
BR (1) BR112018002140B1 (ru)
CA (1) CA2994252A1 (ru)
CL (1) CL2015002153A1 (ru)
CO (1) CO2018001917A2 (ru)
ES (1) ES2783859T3 (ru)
MX (1) MX2018001373A (ru)
PE (1) PE20180577A1 (ru)
PT (1) PT3329019T (ru)
RU (1) RU2707549C2 (ru)
UY (1) UY36819A (ru)
WO (1) WO2017021814A1 (ru)
ZA (1) ZA201800940B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016077366A1 (en) 2014-11-10 2016-05-19 Genentec, Inc. Therapeutic and diagnostic methods for il-33-mediated disorders
CN107172879B (zh) 2014-11-10 2021-11-05 豪夫迈·罗氏有限公司 抗白细胞介素-33抗体及其用途
MX2022011156A (es) 2020-03-13 2022-10-13 Genentech Inc Anticuerpos anti-interleucina-33 y usos de estos.
JP6960642B2 (ja) * 2020-04-16 2021-11-05 国立研究開発法人国立国際医療研究センター 呼吸器感染症の重症化の予測を補助する方法、バイオマーカーの測定値をモニタリングする方法、これらの方法に用いられる試薬キット、呼吸器感染症の重症化の予測を補助する装置およびコンピュータプログラム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008268362A1 (en) * 2007-06-26 2008-12-31 Medimmune, Llc Methods of treating RSV infections and related conditions
KR101286463B1 (ko) * 2011-01-28 2013-07-16 환인제약 주식회사 천궁 추출물을 함유하는 호흡기 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
KR20180028525A (ko) 2018-03-16
BR112018002140A2 (pt) 2018-09-11
CL2015002153A1 (es) 2016-01-29
EP3329019A1 (en) 2018-06-06
PT3329019T (pt) 2020-04-08
MX2018001373A (es) 2018-06-15
UY36819A (es) 2017-01-31
AR105542A1 (es) 2017-10-11
WO2017021814A1 (en) 2017-02-09
BR112018002140B1 (pt) 2024-01-23
US20180327843A1 (en) 2018-11-15
RU2707549C2 (ru) 2019-11-27
CA2994252A1 (en) 2017-02-09
PE20180577A1 (es) 2018-04-04
CO2018001917A2 (es) 2018-05-10
CN108368556A (zh) 2018-08-03
ZA201800940B (en) 2019-07-31
ES2783859T3 (es) 2020-09-18
EP3329019A4 (en) 2018-06-06
US11085080B2 (en) 2021-08-10
KR102621463B1 (ko) 2024-01-04
EP3329019B1 (en) 2020-01-01
CN108368556B (zh) 2021-06-22
RU2018104707A3 (ru) 2019-08-28

Similar Documents

Publication Publication Date Title
WO2017040930A3 (en) Biomarkers predictive of cytokine release syndrome
RU2018104707A (ru) ИСПОЛЬЗОВАНИЕ МОЛЕКУЛЯРНЫХ МАРКЕРОВ IL-3, IL-33 и IL12ρ40 ДЛЯ ХАРАКТЕРИСТИКИ СТЕПЕНИ ТЯЖЕСТИ РЕСПИРАТОРНЫХ ИНФЕКЦИЙ, ВЫЗВАННЫХ РЕСПИРАТОРНО-СИНЦИТИАЛЬНЫМ ВИРУСОМ ЧЕЛОВЕКА И МЕТАПНЕВМОВИРУСОМ ЧЕЛОВЕКА
BR112013009376A2 (pt) métodos para determinar isótipos de anticorpos antifármacos
RU2015136673A (ru) Биомаркеры сахарного диабета 2 типа и их применение
WO2015176066A3 (en) Lpa-associated protein and rna expression
BR112017004899A2 (pt) detecção de proteínas mal dobradas
BRPI0918479A2 (pt) métodos de uso de medições distribuídas para determinar o tamanho de poço não revestido, de detecção de poço não revestido fora de calibre e de rastreamento de tampão químico pelo uso de medições distribuídas e sistema de computador
JP2014095726A5 (ru)
JP2016536012A5 (ru)
BR112016002845A2 (pt) composições e métodos para tratar condições associadas ao complemento
PE20220004A1 (es) Anticuerpos monoclonales especificos para el antigeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, utiles para la deteccion y el diagnostico de la infeccion causada por vrsh
EP4234710A3 (en) Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2015196192A3 (en) Methods and compositions relating to dengue virus
BR112014014307A2 (pt) métodos e kits para detecção in situ à temperatura ambiente de um ácido nucleico alvo em uma amostra biológica
BR112014020513A2 (pt) Métodos e sistemas para amplificação de sinal de bioensaios
WO2015184321A3 (en) Rare molecule detection
WO2016030500A3 (en) Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistance
BR112016015537A2 (pt) métodos e kits para detectar a presença de sequência polinucleotídea da e. histolytica em amostra
EA201490219A1 (ru) Новый способ и набор для предсказания успеха экстракорпорального оплодотворения
WO2018075633A3 (en) Compositions and methods for detecting or quantifying hepatitis c virus
RU2014115725A (ru) Биомаркеры инфекций дыхательных путей
JP2017538786A5 (ru)
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
EA201891170A1 (ru) Биомаркер поликистозной болезни почек и варианты его применения